President Trump's $500 billion Stargate Initiative to build AI infrastructure faces blowback from his conspiracist supporters.

The US Food and Drug Administration (FDA) recently issued its draft guidance, Considerations for the Use of Artificial Intelligence to ...

Allurion catapulted nearly 200% early Friday after the company said it plans to test its weight-loss technology with an ...

The biotech sector in 2025 presents a landscape brimming with both opportunities and challenges. The industry is being shaped ...

In 2024, global and US markets saw a slight increase in IPOs. Syntax Data used its FIS classification system to analyze the ...

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

A specially designed drug prevented laboratory mice from developing heart failure after heart attacks, according to new ...

Allurion stock soars on weight-loss therapy update. Stardust Power breaks ground on Oklahoma lithium refinery. OpenAI ...

A Lloyd's of London company partnered with GATC Health to fund and insure prospective drug trials that pass the test of a new AI technology.

The discovery and development of drugs in pharmacological research – including the risk assessment of active substances in ...

The successful and safe delivery of therapeutics relies on understanding how easily drugs can pass through biological barriers which protect cells.

The biotech scene can be seen as fairly risky for new investors who want to put money to work. After all, it’s really tough to gauge which innovative biotech firms will have something genuinely ground ...